There is a risk-benefit tradeoff within many aspects of our lives—driving is quicker and more convenient, but there is a chance you could get into an accident; junk food tastes good, but it often contains more calories and fat; disposable and refillable e-cigs rid smokers of the effects caused by tobacco and other chemicals found within combustible cigarettes, but they do still contain nicotine. The below clinical trial focuses on the risk-benefit of e-cigs versus combustibles and specifically examines the carcinogen presence in the body and other immediate health risks.
The study
The analysis titled, “Effect of Pod e-Cigarettes vs Cigarettes on Carcinogen Exposure Among African Americans and Latinx Smokers,” consisted of a six-week randomized trial where the e-cigarette use and cigarette use among African American and Latin smokers were documented. The study focused on measuring the concentrations of nicotine, any reduction in potential health risks, as well as used biomarkers to determine carcinogen exposure between the two methods of nicotine delivery. The end goal of the clinical trial was to examine the extreme effects that the everyday use of combustible cigarettes has on the body and determine the risk-benefit tradeoff that’s exhibited when users transition to e-cigs.
Those who participated in the trial possessed a habit of consuming at least five combustibles daily or at least 25 in the past 30 days. They also needed to be interested in quitting.
The study included 186 African American and Latinx adult smokers, some of whom were told to continue to consume their daily number of combustible cigarettes while others were supplied with vaping products in their preferred flavors (5% nicotine concentration levels) along with the education, training, and action planning to help them to prepare for the transition. The selection was randomized and the data was analyzed and collected between September 18, 2019, and September 4, 2020.
What were the results?
The primary outcome from the biomarkers revealed that there was a reduction in urinary 4-(methylnitrosamino)-1-)3-pyridyl)-1-butanol (NNAL) concentration, with secondary outcomes revealing a change in urinary cotinine, expired carbon monoxide, (CO), respiratory symptoms, lung function, and blood pressure at weeks two and six for the e-cig group only.
Co-program leader of KU Cancer Center’s Cancer Prevention and Control research program, Nikki Nollen, Ph.D., acted as site principal investigator.
“What was most surprising was the magnitude of change experienced by those in the e-cigarette group… they reduced their NNAL by 64%, carbon monoxide by 47%, and respiratory symptoms by 38% compared to those in the control group who continued to smoke cigarettes as usual.”
Why should you buy e-cigs online to help you quit smoking?
Aside from the factors mentioned above that take effect after a short six weeks, there are so many benefits from quitting smoking with the help of e-cigs. Needless to say, while you’re able to purchase vape products from specialty stores, nothing beats the experience you get when you buy e-cigs online.
- Since online businesses aren’t paying for the lease of a physical storefront and likely don’t need to hire as many staff, they can offer e-cig products for the best prices.
- You can read customer reviews to compare products before committing to your purchase.
- You’re able to set up a delivery schedule that meets your quantity and frequency needs
If you have questions about how to buy e-cigs online or require further information on the study, drop a comment below.
